About: Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines
Creator	Fournier, Georges Bolton, Damien Chlosta, Piotr De La Rosette, Jean De La, Jean Gkialas, Ioannis Gomez, Reynaldo Gravas, Stavros Klotz, Laurence Kulkarni, Sanjay Oya, Mototsugu Rasyid, Nur Scarpa, Roberto Summerton, Duncan Tanguay, Simon Xie, Li-Ping
source	Elsevier; Medline; PMC
abstract	Abstract Background Determining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations. Objective To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations. Design, setting, and participants Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d’Urologie. Outcome measurements and statistical analysis Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively. Results and limitations There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents’ priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers. Conclusions Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings. Patient summary When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources.
has issue date	2020-06-15(xsd:dateTime)
bibo:doi	10.1016/j.euf.2020.06.006
bibo:pmid	32571743
has license	els-covid
sha1sum (hex)	24d912da9e8e626ac4773163a8d16c3211f3c455
schema:url	https://doi.org/10.1016/j.euf.2020.06.006
resource representing a document's title	Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines
has PubMed Central identifier	PMC7294295
has PubMed identifier	32571743
schema:publication	Eur Urol Focus
resource representing a document's body	covid:24d912da9e8e626ac4773163a8d16c3211f3c455#body_text
is schema:about of	named entity 'urologists' named entity 'COVID-19' named entity 'Guidelines' named entity 'Era' named entity 'LEADING' named entity 'inter' named entity 'associations' named entity 'urologists' named entity 'urological conditions' named entity 'Urological Surgery' named entity 'Urological Surgery' named entity 'double-J' named entity 'urologists' named entity 'Asian' named entity 'orchidectomy' named entity 'retroperitoneal lymph node dissection' named entity 'health care systems' named entity 'Asia' named entity 'urodynamics' named entity 'urologists' named entity 'decision making' named entity 'COVID' named entity 'coronavirus disease 2019' named entity 'urodynamics' named entity 'high-risk' named entity 'tumour' named entity 'double-J' named entity 'Clinical Medicine' named entity 'statistical significance' named entity 'radical prostatectomy' named entity 'ICU' named entity 'nephrectomy' named entity 'radical cystectomy' named entity 'ICU' named entity 'health care' named entity 'Aventri' named entity '3.14' named entity 'health care workers' named entity 'English language' named entity 'resection' named entity 'radical cystectomy' named entity 'COVID' named entity 'clinical setting' named entity 'data analysis' named entity 'health care systems' named entity 'benign prostatic hyperplasia' named entity 'biopsy' named entity 'cystoscopy' named entity 'nephrectomy' named entity 'tumour' named entity 'orchidectomy' named entity 'urologists' named entity 'COVID' named entity 'tumour' named entity 'European Association of Urology' named entity 'Asian' named entity 'penectomy' named entity 'COVID' named entity 'cystoscopy' named entity 'Z-transformed' named entity 'tumour' named entity 'randomised controlled trials' named entity 'outpatient setting' named entity 'BPH' named entity 'nephroureterectomy' named entity 'urologists'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software